Skip to content
Young Kwang Chae, MD, MPH, MBA· @youngkwangchae · X·· 2026-04-20Score60
Body · original

Compelling insights from Dr. Aaron Hata
@MGHMedicine
the multi-step evolution of drug resistance in lung cancer at #AACR26!

Key mechanisms driving relapse:
Therapy-induced adaptive mutagenesis: Targeted treatments drive APOBEC3A expression, leading to genomic instability

Heat 18 · 13 likes · 0 replies · 5 reposts

Source: Young Kwang Chae, MD, MPH, MBA · x.com

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org